ANKS1A

ANKS1A (Odin) is a PTB- and ankyrin-repeat-containing adaptor protein that functions as a cargo-specific sorting factor in COPII-mediated ER-to-cell-surface transport and in receptor tyrosine kinase endocytic trafficking. Upon serine phosphorylation it localizes to the ER, where its ankyrin repeat domain binds NPXY motifs on cargo receptors (EphA2, LRP1) while its PTB domain simultaneously engages the COPII coat subunit Sec23, thereby selectively loading these receptors into COPII vesicles for anterograde transport (PMID:27619642, PMID:38123547). ANKS1A also regulates EGFR post-endocytic fate: it promotes recycling of internalized EGFR to the plasma membrane and suppresses lysosomal degradation, functioning downstream of Src family kinase-mediated tyrosine phosphorylation (PMID:23825523, PMID:18844995). In the postnatal brain, ANKS1A is required for ependymal cell differentiation and restricts intraflagellar transport entry into multicilia, thereby controlling ciliary membrane protein homeostasis (PMID:30759972, PMID:38052491).

1. 2008 Medium

   Identifying ANKS1A as a Src family kinase substrate established it as a signaling-responsive phosphoprotein in cancer cells, raising the question of what biological process its phosphorylation controls.

   Evidence SH2 affinity chromatography and mass spectrometry in SW620 colorectal cancer cells with SFK inhibitor validation

   PMID:18844995

   Open questions at the time

   • Specific phosphorylation sites were not mapped
   • Functional consequence of SFK-dependent phosphorylation was not determined
   • Single cell line; generality unknown
2. 2013 Medium

   Demonstrating that ANKS1A directs internalized EGFR toward recycling endosomes and away from lysosomes revealed a trafficking-regulatory function, connecting its phosphorylation to receptor fate decisions.

   Evidence Overexpression and siRNA knockdown in HEK293 and RVH6849 cells with EGFR recycling and degradation assays

   PMID:23825523

   Open questions at the time

   • Mechanism by which ANKS1A diverts EGFR from the lysosomal pathway was not defined
   • Direct EGFR–ANKS1A physical interaction at endosomes was not shown
   • Single lab; not independently replicated
3. 2016 High

   Reconstituting ANKS1A as a COPII cargo adaptor — binding EphA2 via ankyrin repeats and Sec23 via the PTB domain at ER exit sites — resolved its molecular mechanism in anterograde trafficking and explained how specific receptors are selected for ER export.

   Evidence Co-IP, domain mutagenesis, COPII vesicle reconstitution, Anks1a knockout mice, knockdown in primary mammary tumor cells

   PMID:27619642 PMID:27802842

   Open questions at the time

   • Structural basis of the ankyrin-repeat–NPXY and PTB–Sec23 interfaces not resolved
   • Whether ANKS1A acts on other NPXY-containing cargoes beyond EphA2/ErbB2 was unknown at this point
4. 2019 Medium

   Showing that Anks1a loss prevents ependymal cell differentiation in the postnatal brain extended its function from receptor trafficking to a developmental cell-fate decision, linking its adaptor activity to brain homeostasis.

   Evidence Anks1a-deficient mouse analysis, gene-trap reporter, in vivo neonatal overexpression

   PMID:30759972

   Open questions at the time

   • Which cargo(es) must be trafficked by ANKS1A for ependymal differentiation was not identified
   • Single lab; mechanistic link to COPII pathway in this context not tested
5. 2022 Low

   Detection of an ANKS1A–active-Rac1 interaction at the leading edge of migrating breast cancer cells suggested a possible additional role in cell migration, though this was attributed to its effects on EGFR trafficking rather than direct Rac1 effector function.

   Evidence Co-immunoprecipitation with GTP-Rac1, live-cell migration assays, esiRNA knockdown in breast cancer lines

   PMID:36717454

   Open questions at the time

   • Single Co-IP without reciprocal or domain-mapping validation
   • Causality between Rac1 binding and migration phenotype not distinguished from EGFR trafficking effects
   • Single lab, partial mechanistic resolution
6. 2023 High

   Extending the COPII adaptor model to LRP1 in brain endothelial cells — and linking ANKS1A deficiency to impaired amyloid-β transcytosis — generalized the cargo adaptor mechanism and established disease relevance for blood-brain barrier function.

   Evidence Co-IP of ANKS1A–LRP1 NPXY interaction, endothelial-specific KO mouse, iPSC-derived BBB model, Aβ transcytosis assays, gene therapy rescue

   PMID:38123547

   Open questions at the time

   • Whether the ANKS1A rs6930932 variant is a genetic risk factor for Alzheimer's disease in population studies was not established
   • Full repertoire of NPXY-containing cargoes handled by ANKS1A in vivo remains undefined
7. 2023 Medium

   Revealing that ANKS1A restricts IFT entry into ependymal multicilia and controls ciliary membrane protein (Vangl2) and extracellular vesicle homeostasis added a cilia-regulatory dimension to its function beyond ER export.

   Evidence Immunofluorescence of IFT88 and Vangl2 in ANKS1A-deficient ependymal cells, primary culture ECV analysis

   PMID:38052491

   Open questions at the time

   • Molecular mechanism by which ANKS1A restricts IFT entry is unknown
   • Whether this ciliary function depends on the same PTB–Sec23 interaction used in COPII trafficking is untested
   • Single lab with imaging-based readout

• How ANKS1A's COPII adaptor function, endocytic recycling role, and ciliary IFT-restriction activity are coordinated — and whether they share a common PTB/ankyrin-dependent mechanism — remains unresolved.
• No structural data for any ANKS1A domain–partner interface
• Complete in vivo cargo repertoire unknown
• Relationship between serine phosphorylation-dependent ER localization and tyrosine phosphorylation by SFKs is undefined